Anti-CD7 CE/IVD antibodies are essential tools for the identification and characterization of T cell lineage and natural killer (NK) cells in formalin-fixed, paraffin-embedded (FFPE) tissues. These antibodies enable accurate immunohistochemical (IHC) analysis for T cell neoplasms and detection of aberrant expression patterns in hematologic malignancies.
Biological Significance of CD7
- CD7 is a type I transmembrane glycoprotein belonging to the immunoglobulin superfamily.
- Expressed early during thymic T cell development and maintained on most mature T cells and NK cells.
- Functions in T-cell interactions during immune responses.
- Loss or reduced expression can occur physiologically in certain T cell subsets.
- Aberrant expression or loss of CD7 is observed in various hematologic malignancies, reflecting differentiation status or disease-specific immunophenotypes.
Diagnostic Utility in Hematopathology
- T cell lineage identification: Sensitive marker for T cell acute lymphoblastic leukemia (T-ALL) and peripheral T cell neoplasms; commonly used in panels with CD2, CD3, CD4, and CD5.
- Aberrant expression: Occasional expression in subsets of acute myeloid leukemia (AML) may indicate immature differentiation.
- Cutaneous T cell lymphomas: Loss or reduced expression is characteristic of mycosis fungoides and Sézary syndrome, aiding differential diagnosis when combined with other T cell markers.
Key Features of CD7 CE/IVD Antibodies for IHC
- High specificity and sensitivity for normal and aberrant CD7 expression.
- Optimized for FFPE tissue compatibility and routine clinical use.
- Integrates seamlessly into multiparametric panels for improved diagnostic accuracy.
- Validated for reproducibility with optimized antigen retrieval and consistent staining across control tissues.
